James E Flynn Insider Trading for December 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James E Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of James E Flynn for December 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 2015 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 8.97 | 3,239 | 29,042 | 1,103,617 | 1.1 M to 1.1 M (+0.29 %) |
| Dec 18 2015 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 8.97 | 4,441 | 39,820 | 2,740,122 | 2.7 M to 2.7 M (+0.16 %) |
| Dec 18 2015 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 8.97 | 3,490 | 31,293 | 2,152,952 | 2.1 M to 2.2 M (+0.16 %) |
| Dec 17 2015 | LANV | STREAMLINE HEALTH ... | Flynn James E | 10% Owner | Sell | S | 1.20 | 226,000 | 271,968 | 1,875,500 | 2.1 M to 1.9 M (-10.75 %) |
| Dec 17 2015 | LANV | STREAMLINE HEALTH ... | Flynn James E | 10% Owner | Sell | S | 1.23 | 116,464 | 142,831 | 2,101,500 | 2.2 M to 2.1 M (-5.25 %) |
| Dec 17 2015 | LANV | STREAMLINE HEALTH ... | Flynn James E | 10% Owner | Sell | S | 1.34 | 54,795 | 73,486 | 2,217,964 | 2.3 M to 2.2 M (-2.41 %) |
| Dec 11 2015 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 8.61 | 93,634 | 806,086 | 1,100,378 | 1 M to 1.1 M (+9.30 %) |
| Dec 11 2015 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 8.61 | 128,374 | 1,105,159 | 2,726,895 | 2.6 M to 2.7 M (+4.94 %) |
| Dec 11 2015 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 8.61 | 100,864 | 868,328 | 2,158,248 | 2.1 M to 2.2 M (+4.90 %) |
| Dec 11 2015 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 8.59 | 29,902 | 256,864 | 1,006,744 | 976.8 K to 1 M (+3.06 %) |
| Dec 11 2015 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 8.59 | 32,211 | 276,699 | 2,598,521 | 2.6 M to 2.6 M (+1.26 %) |
| Dec 11 2015 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 8.59 | 40,997 | 352,172 | 2,057,384 | 2 M to 2.1 M (+2.03 %) |
| Dec 11 2015 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 9.00 | 11,506 | 103,554 | 976,842 | 965.3 K to 976.8 K (+1.19 %) |
| Dec 11 2015 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 9.00 | 15,775 | 141,975 | 2,566,310 | 2.6 M to 2.6 M (+0.62 %) |
| Dec 11 2015 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 9.00 | 12,395 | 111,555 | 2,016,387 | 2 M to 2 M (+0.62 %) |
| Dec 11 2015 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 8.21 | 213,358 | 1,751,883 | 965,336 | 752 K to 965.3 K (+28.37 %) |
| Dec 11 2015 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 8.21 | 292,515 | 2,401,841 | 2,550,535 | 2.3 M to 2.6 M (+12.95 %) |
| Dec 11 2015 | VNDA | Vanda Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 8.21 | 229,833 | 1,887,159 | 2,003,992 | 1.8 M to 2 M (+12.95 %) |
| Dec 08 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.04 | 27,530 | 83,774 | 728,718 | 701.2 K to 728.7 K (+3.93 %) |
| Dec 08 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.04 | 27,529 | 83,771 | 4,760,408 | 4.7 M to 4.8 M (+0.58 %) |
| Dec 08 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 68,294 | 204,848 | 701,188 | 632.9 K to 701.2 K (+10.79 %) |
| Dec 08 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 68,294 | 204,848 | 4,732,879 | 4.7 M to 4.7 M (+1.46 %) |
| Dec 08 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.01 | 40,301 | 121,169 | 632,894 | 592.6 K to 632.9 K (+6.80 %) |
| Dec 08 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.01 | 40,301 | 121,169 | 4,664,585 | 4.6 M to 4.7 M (+0.87 %) |
| Dec 03 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 53,487 | 160,589 | 592,593 | 539.1 K to 592.6 K (+9.92 %) |
| Dec 03 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 53,486 | 160,586 | 4,624,284 | 4.6 M to 4.6 M (+1.17 %) |
| Dec 03 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 2.98 | 55,257 | 164,876 | 539,106 | 483.8 K to 539.1 K (+11.42 %) |
| Dec 03 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 2.98 | 55,257 | 164,876 | 4,570,798 | 4.5 M to 4.6 M (+1.22 %) |
| Dec 03 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.05 | 12,882 | 39,273 | 483,849 | 471 K to 483.8 K (+2.74 %) |
| Dec 03 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.05 | 12,883 | 39,276 | 4,515,541 | 4.5 M to 4.5 M (+0.29 %) |